Join to View Full Profile
601 Elmwood Ave"# 320"Rochester, NY 14642
Phone+1 585-275-8748
Fax+1 585-273-3637
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Hiroshi Miyamoto, MD is a board certified pathologist in Rochester, New York. He is currently licensed to practice medicine in New York and Maryland. He is an Associate Professor of Pathology at Johns.
Education & Training
Yokohama City University School of MedicineClass of 1988
Certifications & Licensure
NY State Medical License 2008 - 2026
MD State Medical License 2013 - 2017
American Board of Pathology Pathology - Anatomic
Publications & Presentations
PubMed
- TRPS1 is a useful marker in differentiating metastatic breast carcinoma from pancreatic adenocarcinoma in fine-needle aspiration specimens.Bahadir Yildiz, Jerome Jean-Gilles Jr, Ellen J Giampoli, Sierra Kovar-Peltz, Qi Yang
American Journal of Clinical Pathology. 2025-04-19 - 2 citationsClinical significance of location of perineural cancer invasion detected on prostate needle core biopsy.Benjamin G Gertsen, Yuki Teramoto, Ying Wang, Toyonori Tsuzuki, Hiroshi Miyamoto
Virchows Archiv. 2025-02-01 - 1 citationsCribriform intraductal carcinoma of the prostate may be more aggressive than cribriform conventional/acinar prostatic adenocarcinoma.Ying Wang, Yuki Teramoto, Hiroshi Miyamoto
Pathology. 2025-02-01
Press Mentions
Inadequate Grading of Intraductal Carcinoma of the ProstateMarch 28th, 2025- Inadequate Grading of Intraductal Carcinoma of the ProstateMarch 28th, 2025
- Time-Dependent Efficacy of Combination of Silver-Containing Hydroxyapatite Coating and Vancomycin on Methicillin-Resistant Staphylococcus Aureus Biofilm Formation in VitroMarch 2nd, 2021
- Join now to see all
